BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 26065674)

  • 1. From cardiac tissue engineering to heart-on-a-chip: beating challenges.
    Zhang YS; Aleman J; Arneri A; Bersini S; Piraino F; Shin SR; Dokmeci MR; Khademhosseini A
    Biomed Mater; 2015 Jun; 10(3):034006. PubMed ID: 26065674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards chamber specific heart-on-a-chip for drug testing applications.
    Zhao Y; Rafatian N; Wang EY; Wu Q; Lai BFL; Lu RX; Savoji H; Radisic M
    Adv Drug Deliv Rev; 2020; 165-166():60-76. PubMed ID: 31917972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
    Watson DE; Hunziker R; Wikswo JP
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioengineering methods for myocardial regeneration.
    Parsa H; Ronaldson K; Vunjak-Novakovic G
    Adv Drug Deliv Rev; 2016 Jan; 96():195-202. PubMed ID: 26150344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organ-On-A-Chip Platforms: A Convergence of Advanced Materials, Cells, and Microscale Technologies.
    Ahadian S; Civitarese R; Bannerman D; Mohammadi MH; Lu R; Wang E; Davenport-Huyer L; Lai B; Zhang B; Zhao Y; Mandla S; Korolj A; Radisic M
    Adv Healthc Mater; 2018 Jan; 7(2):. PubMed ID: 29034591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrical and mechanical stimulation of cardiac cells and tissue constructs.
    Stoppel WL; Kaplan DL; Black LD
    Adv Drug Deliv Rev; 2016 Jan; 96():135-55. PubMed ID: 26232525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered platforms for mimicking cardiac development and drug screening.
    Stiefbold M; Zhang H; Wan LQ
    Cell Mol Life Sci; 2024 Apr; 81(1):197. PubMed ID: 38664263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering Cardiac Tissue for Advanced Heart-On-A-Chip Platforms.
    Chen X; Liu S; Han M; Long M; Li T; Hu L; Wang L; Huang W; Wu Y
    Adv Healthc Mater; 2024 Jan; 13(1):e2301338. PubMed ID: 37471526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomaterial based cardiac tissue engineering and its applications.
    Huyer LD; Montgomery M; Zhao Y; Xiao Y; Conant G; Korolj A; Radisic M
    Biomed Mater; 2015 May; 10(3):034004. PubMed ID: 25989939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomimetic microsystems for cardiovascular studies.
    Inbody SC; Sinquefield BE; Lewis JP; Horton RE
    Am J Physiol Cell Physiol; 2021 May; 320(5):C850-C872. PubMed ID: 33760660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of functional cardiac microtissues in a beating heart-on-a-chip.
    Ugolini GS; Visone R; Cruz-Moreira D; Mainardi A; Rasponi M
    Methods Cell Biol; 2018; 146():69-84. PubMed ID: 30037467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering Cardiac Muscle Tissue: A Maturating Field of Research.
    Weinberger F; Mannhardt I; Eschenhagen T
    Circ Res; 2017 Apr; 120(9):1487-1500. PubMed ID: 28450366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered approaches to the stem cell microenvironment for cardiac tissue regeneration.
    Ghafar-Zadeh E; Waldeisen JR; Lee LP
    Lab Chip; 2011 Sep; 11(18):3031-48. PubMed ID: 21785806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next generation human skin constructs as advanced tools for drug development.
    Abaci HE; Guo Z; Doucet Y; Jacków J; Christiano A
    Exp Biol Med (Maywood); 2017 Nov; 242(17):1657-1668. PubMed ID: 28592171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in cardiac tissue engineering and heart-on-a-chip.
    Kieda J; Shakeri A; Landau S; Wang EY; Zhao Y; Lai BF; Okhovatian S; Wang Y; Jiang R; Radisic M
    J Biomed Mater Res A; 2024 Apr; 112(4):492-511. PubMed ID: 37909362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstructing the heart using iPSCs: Engineering strategies and applications.
    Cho S; Lee C; Skylar-Scott MA; Heilshorn SC; Wu JC
    J Mol Cell Cardiol; 2021 Aug; 157():56-65. PubMed ID: 33895197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design Approaches to Myocardial and Vascular Tissue Engineering.
    Akintewe OO; Roberts EG; Rim NG; Ferguson MAH; Wong JY
    Annu Rev Biomed Eng; 2017 Jun; 19():389-414. PubMed ID: 28471698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Content Assessment of Cardiac Function Using Heart-on-a-Chip Devices as Drug Screening Model.
    Conant G; Lai BFL; Lu RXZ; Korolj A; Wang EY; Radisic M
    Stem Cell Rev Rep; 2017 Jun; 13(3):335-346. PubMed ID: 28429185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomimetic tissues on a chip for drug discovery.
    Ghaemmaghami AM; Hancock MJ; Harrington H; Kaji H; Khademhosseini A
    Drug Discov Today; 2012 Feb; 17(3-4):173-81. PubMed ID: 22094245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.